David B. Elsbree
CIK: 0001292650
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
T2 Biosystems, Inc.
Discretionary Trading P&L
Holdings
David B. Elsbree files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by David B. Elsbree since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.
About Elsbree David B
Elsbree David B (SEC CIK 0001292650) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).
Signal8 holds 2 ownership filings by Elsbree David B, all Form 4s, filed between Sep 17, 2024 and Jan 2, 2025. Those filings report 2 transactions, from Sep 13, 2024 to Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Elsbree David B's filings is in LEXINGTON, MA.
Recent filings by Elsbree David B
Other insiders filing for T2 Biosystems, Inc. (TTOO)
- LIEBMAN SEYMOUR, Director
- Giffin Brett A., Chief Commercial Officer
- Adams Laura Lee, Director
- CUMMING JOHN W, Director
- Gibbs Michael Terrence, General Counsel
- Saunders Ninfa, Director